Enovis Corporation
HealthcareNYSE:ENOV · New York Stock Exchange
+$0.68 today
Vol 0.91M · Avg 0.98M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-79.5%
avg -9.7%
ROIC
-0.6%
avg -0.9%
ROA
-30.9%
avg -4.2%
Analysis
ROIC is currently the strongest return metric at -0.6% versus its period average of -0.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Damien McDonald | Chief Executive Officer & Director | $2.34M | — | 61 | $234,042.00 | 0.41% |
Phillip Benjamin Berry | Senior Vice President & Chief Financial Officer | $1.11M | — | 47 | $150,822.00 | 0.26% |
Terry Ross | Group President Prevention & Recovery | $969,399.00 | — | 56 | $68,477.00 | 0.12% |
Patricia A. Lang | Advisor | $928,840.00 | — | 67 | $75,703.00 | 0.13% |
Laura Singleton | Senior Vice President & Chief Human Resources Officer | $896,341.00 | — | — | $15,552.00 | 0.03% |
Bradley J. Tandy | Senior Vice President & Chief Legal Officer | $874,354.00 | — | 67 | $65,641.00 | 0.11% |
Louie Vogt | Group President of Reconstructive | $867,128.00 | — | 45 | $68,875.00 | 0.12% |
Oliver Engert | Chief Administrative Officer | — | — | 61 | $50,640.00 | 0.09% |
John Kleckner | Vice President, Controller & Chief Accounting Officer | — | — | 49 | $25,884.00 | 0.04% |
Kyle William Rose | Vice President of Investor Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
15
$929,725.05
Sells
4
$45,297.99
Net Sentiment
+$884,427.06
Net buying
Most Active
Engert Oliver
10 transactions
1–10 of 19
Analysis
Insiders reported 15 buys worth $929,725.05 and 4 sells worth $45,297.99 over the last 12 months. That adds up to net buying of $884,427.06. Engert Oliver was the most active insider with 10 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | +0.7% (13yr)2 analysts |
| Revenue | N/A | N/A | +0.5% | -3.2% (13yr)6 analysts |
| Net Income | N/A | N/A | N/A | +3.1% (13yr)6 analysts |
| EBIT | N/A | N/A | +26.7% | N/A6 analysts |
Analysis
Recent growth has been strongest in EBIT at +26.7% over three years. Forward estimates point to Net Income at +3.1% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
ITT Inc.
NYSE:ITT
$16.91B
IDEX Corporation
NYSE:IEX
$16.17B
Watts Water Technologies, Inc.
NYSE:WTS
$11.12B
Donaldson Company, Inc.
NYSE:DCI
$10.01B
The Middleby Corporation
NASDAQ:MIDD
$7.17B
EnPro Industries, Inc.
NYSE:NPO
$7.07B
Franklin Electric Co., Inc.
NASDAQ:FELE
$4.58B
Kadant Inc.
NYSE:KAI
$3.34B
Helios Technologies, Inc.
NYSE:HLIO
$2.80B
The Gorman-Rupp Company
NYSE:GRC
$2.23B
Enerpac Tool Group Corp.
NYSE:EPAC
$1.85B
Graham Corporation
NYSE:GHM
$1.21B
Luxfer Holdings PLC
NYSE:LXFR
$488.28M
Omega Flex, Inc.
NASDAQ:OFLX
$311.71M
Hurco Companies, Inc.
NASDAQ:HURC
$139.89M
Who manages ENOV?
Enovis Corporation (ENOV) lists 10 active executives. The top listed executive is Patricia A. Lang, Advisor.
Are ENOV insiders buying or selling?
Recent insider activity shows net selling of $11.03M.
Explore More
Continue the stock analysis
Jump to another research area for this company.